Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) StudySigne Westring Worm, Jens Lundgren, Andrew Phillips et al.|The Journal of Infectious Diseases|2009Cited by 649
Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs StudyNina Friis‐Møller, Rodolphe Thiébaut, Peter Reiss et al.|European Journal of Cardiovascular Prevention & Rehabilitation|2010Cited by 392
Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study*Kathy Petoumenos, Signe Westring Worm, Peter Reiss et al.|HIV Medicine|2011Cited by 189
Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease eventsAntonella d’Arminio Monforte, Caroline Sabin, Peter Reiss et al.|AIDS|2013Cited by 108
Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency VirusSigne Westring Worm, Nina Friis‐Møller, Stéphane De Wit et al.|Circulation|2009Cited by 96